Entrar/Registro  
HOME SPANISH
 
Cirugía y Cirujanos
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Cirugía y Cirujanos >Year 2011, Issue 5


Escobedo-de la Peña J, Buitrón-Granados LV, Ramírez-Martínez JC, Chavira-Mejía R, Schargrodsky H, Marcet CB
Diabetes in Mexico. Carmela study
Cir Cir 2011; 79 (5)

Language: Español
References: 32
Page: 424-431
PDF: 450.94 Kb.

[Full text - PDF]

ABSTRACT

Background: Diabetes has demonstrated an epidemic behavior in Mexico, which is among the top countries with the highest number of patients with diabetes. The objective of this study was to estimate the prevalence of type 2 diabetes in Mexico City and its relation with some cardiovascular risk factors.
Methods: A cross-sectional study was conducted. A total of 1,772 adults of both genders, aged 25 to 64 years, were randomly selected. Type 2 diabetes and impaired fasting glucose prevalence were estimated as well as its relation with some cardiovascular risk factors such as hypertension, dyslipidemia, obesity, abdominal obesity and the common carotid artery intima-media thickness.
Results: The prevalence of type 2 diabetes was 9.7% in women and 8.0% in men. An age effect was evident. The proportion of patients who were unaware of having diabetes was 26%. The main risk factors related to diabetes were age, abdominal obesity, hypertension, low high-density cholesterol lipoproteins (HDL-c) and hypertriglyceridemia. Metabolic control was low.
Conclusions: Prevalence of type 2 diabetes in Mexico is high and is a major health problem. Its close relation with cardiovascular risk factors demand health policies aimed to diminish risk factors related to its occurrence.


Key words: Type 2 diabetes, prevalence, cardiovascular risk factors.


REFERENCES

  1. Rull JA, Aguilar-Salinas CA, Rojas R, Ríos-Torres JM, Gómez-Pérez F, Olaiz G. Epidemiology of type 2 diabetes in México. Arch Med Res 2005;36:188-196.

  2. International Diabetes Federation. IDF Diabetes Atlas. Prevalence estimates of diabetes mellitus (DM), 2030. Disponible en http://www.diabetesatlas.org/content/prevalence-estimates-diabetes-mellitus-dm-2030

  3. Vázquez-Robles M, Escobedo-de la Peña J. Análisis de la mortalidad por diabetes mellitus en el Instituto Mexicano del Seguro Social (1979-1987). Rev Med IMSS 1990;157-170.

  4. Dirección General de Información en Salud. Sistema Nacional de Información en Salud. Información 2000-2008: Principales causas de mortalidad en mujeres y en hombres. México: Secretaría de Salud. Disponible en http://sinais.salud.gob.mx/mortalidad/index.html

  5. Rodríguez-Ábrego G, Escobedo-de la Peña J, Zurita B, Ramírez TJ. Muerte prematura y discapacidad en los derechohabientes del Instituto Mexicano del Seguro Social. Salud Publica Mex 2007;49:132-143.

  6. Escobedo-de la Peña J, Santos-Burgoa C. La diabetes mellitus y la transición de la atención a la salud. Salud Publica Mex 1995;37:37-46.

  7. Arredondo A, Zúñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries. Diabetes Care 2004;27:104-109.

  8. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2003. p. 100.

  9. Stern MP, González C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992;41:484-492.

  10. Vázquez-Robles M, Romero-Romero E, Escandón-Romero C, Escobedo-de la Peña J. Prevalencia de diabetes mellitus no insulinodependiente y factores de riesgo asociados en una población de México, D. F. Gac Med Mex 1993;129:191-199.

  11. Posadas-Romero C, Yamamoto-Kimura L, Lerman-Garber I, Zamora-González J, Fajardo-Gutiérrez A, Velásquez L, et al. The prevalence of NIDDM and associated coronary risk factors in Mexico City. Diabetes Care 1994;17:1441-1448.

  12. Escobedo-de la Peña J, Islas S, Lifshitz-Guinzberg A, Méndez JD, Revilla C, Vázquez-Estupiñán F. Higher prevalence of diabetes in hypertensive subjects with upper body fat distribution. Rev Invest Clin 1998;50:5-12.

  13. Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008;121:58-65.

  14. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004;18:346-349.

  15. Escobedo-de la Peña J, Rico-Verdín B. Incidencia y letalidad de las complicaciones agudas y crónicas de la diabetes mellitus en México. Salud Publica Mex 1996;38:236-242.

  16. Burke JP, Williams K, Haffner SM, González-Villalpando C, Stern MP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001;24:1573-1578.

  17. Zubirán S, Chávez A. Estudio epidemiológico de diabetes en la ciudad de México. Rev Invest Clin 1964;16:367-383.

  18. Pérez Hidalgo C, Chávez A, Serrano O, Zubirán S. Encuesta sobre diabetes en “una muestra” de obreros. Rev Invest Clin 1964;16:385-395.

  19. Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, et al. Effect of aging on glucose homeostasis. Diabetes Care 2008;31:539-543.

  20. Meigs JB, Muller DC, Natham DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003;52:1475-1484.

  21. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss L, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care 2004;27:2806-2812.

  22. Aguilar-Salinas CA, Velázquez-Monroy O, Gómez-Pérez FJ, González-Chávez A, Lara-Esqueda A, Molina-Cuevas V, et al. Characteristics of patients with type 2 diabetes in México. Diabetes Care 2003;26:2021-2026.

  23. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care 2008;31:81-86.

  24. Escobedo J, Rana JS, Lombardero MS, Albert SG, Davis AM, Kennedy FP, et al. Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D Study. Mayo Clin Proc 2010;85:41-46.

  25. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: The Women’s Health Study. Eur Heart J 2007;28:2937-2943.

  26. Olafsdottir E, Aspelund T, Sigurdsson G, Thorsson B, Benediktsson R, Harris TB, et al. Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik). Eur J Epidemiol 2009;24:307-314.

  27. Tirosh A, Shai I, Bitzur R. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008;31:2032-2037.

  28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001;285:2486-2497.

  29. He Y, Zhai F, Ma G, Feskens EJ, Zhang J, Fu P, et al. Abdominal obesity and the prevalence of diabetes and intermediate hyperglycaemia in Chinese adults. Public Health Nutr 2009;12:1078-1084.

  30. Hunt KJ, Williams K, Rivera D, O’Leary DH, Haffner SM, Stern MP, et al. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol 2003;23:1845-1850.

  31. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, et al. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol 2009;8:52.

  32. Acosta-Cázares B, Escobedo-de la Peña J. High burden of cardiovascular disease risk factors in Mexico: an epidemic of ischemic heart disease that may be on its way? Am Heart J 2010;160:230-236.






>Journals >Cirugía y Cirujanos >Year 2011, Issue 5
 

· Journal Index 
· Links 
       
Copyright 2010